396 related articles for article (PubMed ID: 36307879)
1. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Shen L; Gu P; Qiu C; Ding WT; Zhang L; Cao WY; Li ZY; Yan B; Sun X
Ann Hepatol; 2022; 27(3):100680. PubMed ID: 35108614
[TBL] [Abstract][Full Text] [Related]
3. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
Sun Q; Liu X; Peng Q; Hu L; Jiang X
J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
Sun Q; Fu C; Liu J; Li S; Zheng J
Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
7. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma.
Huang N; Zhang J; Kuang S; Li Z; Zhao H; Wu J; Liu M; Wang L
Cancer Med; 2023 Apr; 12(7):8991-9004. PubMed ID: 36680322
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma.
Lu Y; Liang H; Li X; Chen H; Yang C
Aging (Albany NY); 2023 May; 15(11):4699-4713. PubMed ID: 37294538
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Front Immunol; 2022; 13():831101. PubMed ID: 35371079
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
12. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of
Lin T; Zhang E; Lin Z; Peng L
Int J Gen Med; 2021; 14():9117-9130. PubMed ID: 34876845
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
18. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
Front Immunol; 2022; 13():892750. PubMed ID: 35812416
[TBL] [Abstract][Full Text] [Related]
19. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
Wang T; Chen B; Meng T; Liu Z; Wu W
Bioengineered; 2021 Dec; 12(1):1555-1575. PubMed ID: 33955820
[TBL] [Abstract][Full Text] [Related]
20. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.
Zhang H; Xu K; Xiang Q; Zhao L; Tan B; Ju P; Lan X; Liu Y; Zhang J; Fu Z; Li C; Wang J; Song J; Xiao Y; Cheng Z; Wang Y; Zhang S; Xiang T
Genes Dis; 2022 Jan; 9(1):151-164. PubMed ID: 35005115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
